SARM1
Basic information
Region (hg38): 17:28364356-28404049
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (2 variants)
- Congenital defect of folate absorption (1 variants)
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SARM1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 7 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 98 | 28 | 27 | 157 | ||
Total | 2 | 2 | 106 | 28 | 27 |
Highest pathogenic variant AF is 0.0000854
Variants in SARM1
This is a list of pathogenic ClinVar variants found in the SARM1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-28364359-G-C | not specified | Uncertain significance (Jul 14, 2023) | ||
17-28364393-A-G | not specified | Likely benign (Oct 14, 2023) | ||
17-28364428-C-T | not specified | Uncertain significance (Apr 08, 2024) | ||
17-28364429-G-A | not specified | Uncertain significance (Aug 20, 2024) | ||
17-28364549-C-T | not specified | Uncertain significance (Jan 06, 2023) | ||
17-28364801-C-G | not specified | Uncertain significance (Jun 05, 2023) | ||
17-28364834-G-C | not specified | Uncertain significance (Apr 18, 2023) | ||
17-28364853-T-C | not specified | Uncertain significance (Mar 28, 2024) | ||
17-28364928-C-T | not specified | Likely benign (Apr 04, 2024) | ||
17-28364929-G-A | not specified | Uncertain significance (Nov 14, 2023) | ||
17-28364953-C-T | not specified | Uncertain significance (Dec 18, 2023) | ||
17-28365162-A-G | not specified | Likely benign (Dec 12, 2023) | ||
17-28365177-G-A | not specified | Uncertain significance (Apr 19, 2023) | ||
17-28365227-C-T | not specified | Uncertain significance (Dec 06, 2023) | ||
17-28367362-C-CT | VTN-related disorder | Likely benign (Nov 03, 2023) | ||
17-28367411-G-A | Likely benign (Feb 09, 2018) | |||
17-28367413-T-C | not specified | Uncertain significance (May 14, 2024) | ||
17-28367424-T-C | VTN-related disorder | Uncertain significance (Oct 20, 2022) | ||
17-28367431-G-A | not specified | Uncertain significance (Aug 02, 2021) | ||
17-28367440-T-C | not specified | Likely benign (May 23, 2023) | ||
17-28367455-T-A | not specified | Uncertain significance (Sep 06, 2022) | ||
17-28367457-C-A | not specified | Uncertain significance (May 09, 2024) | ||
17-28367462-A-G | VTN-related disorder | Benign (Nov 08, 2019) | ||
17-28367463-T-C | not specified | Uncertain significance (Jul 27, 2024) | ||
17-28367725-G-T | not specified | Uncertain significance (May 23, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SARM1 | protein_coding | protein_coding | ENST00000457710 | 9 | 36688 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.70e-10 | 0.380 | 5545 | 120044 | 4 | 125593 | 0.790 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.90 | 269 | 372 | 0.722 | 0.0000226 | 4301 |
Missense in Polyphen | 107 | 152.61 | 0.70113 | 1712 | ||
Synonymous | 1.69 | 141 | 169 | 0.834 | 0.0000105 | 1511 |
Loss of Function | 1.03 | 18 | 23.4 | 0.770 | 0.00000104 | 278 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 4.00 | 2.68 |
Ashkenazi Jewish | 2.00 | 0.794 |
East Asian | 2.00 | 0.834 |
Finnish | 2.00 | 0.817 |
European (Non-Finnish) | 2.00 | 0.794 |
Middle Eastern | 2.00 | 0.834 |
South Asian | 2.00 | 0.771 |
Other | 2.00 | 0.806 |
dbNSFP
Source:
- Function
- FUNCTION: Negative regulator of MYD88- and TRIF-dependent toll- like receptor signaling pathway which plays a pivotal role in activating axonal degeneration following injury. Promotes Wallerian degeneration an injury-induced axonal death pathway which involves degeneration of an axon distal to the injury site. Can activate neuronal death in response to stress. Regulates dendritic arborization through the MAPK4-JNK pathway. Involved in innate immune response. Inhibits both TICAM1/TRIF- and MYD88- dependent activation of JUN/AP-1, TRIF-dependent activation of NF- kappa-B and IRF3, and the phosphorylation of MAPK14/p38. {ECO:0000269|PubMed:15123841, ECO:0000269|PubMed:16964262, ECO:0000269|PubMed:16985498, ECO:0000269|PubMed:20306472}.;
- Pathway
- Regulation of toll-like receptor signaling pathway;Toll Like Receptor 3 (TLR3) Cascade;Toll-Like Receptors Cascades;Innate Immune System;Immune System;Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon;IKK complex recruitment mediated by RIP1;TRAF6-mediated induction of TAK1 complex within TLR4 complex;TRIF(TICAM1)-mediated TLR4 signaling ;MyD88-independent TLR4 cascade ;Toll Like Receptor 4 (TLR4) Cascade
(Consensus)
Recessive Scores
- pRec
- 0.125
Haploinsufficiency Scores
- pHI
- 0.198
- hipred
- N
- hipred_score
- 0.439
- ghis
- 0.540
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.779
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sarm1
- Phenotype
- immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cellular phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- signal transduction;response to glucose;positive regulation of signal transduction;negative regulation of MyD88-independent toll-like receptor signaling pathway;regulation of apoptotic process;innate immune response;response to axon injury;regulation of dendrite morphogenesis;regulation of neuron death
- Cellular component
- cytoplasm;mitochondrion;cytosol;microtubule;cell junction;axon;dendrite;extrinsic component of mitochondrial outer membrane;synapse
- Molecular function
- protein binding;signaling adaptor activity